Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-19

FDA Approved: DG HEALTH NAPROXEN SODIUM — Supplemental Application (Dolgencorp Inc)

View source ↗

Summary

FDA approved a supplemental application for DG Health Naproxen Sodium (naproxen sodium) by Dolgencorp Inc. The action approves the generic product under the AND…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DG HEALTH NAPROXEN SODIUM (naproxen sodium)

Snippet

SUPPL AP for DG HEALTH NAPROXEN SODIUM (NAPROXEN SODIUM)